Etubics Corporation - Product Pipeline Review - 2016

  • ID: 3635637
  • Company Profile
  • 35 pages
  • Global Markets Direct
1 of 4
Etubics Corporation - Product Pipeline Review - 2016

Summary

The report ‘Etubics Corporation - Product Pipeline Review - 2016’, provides an overview of the Etubics Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Etubics Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Etubics Corporation
- The report provides overview of Etubics Corporation including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Etubics Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Etubics Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Etubics Corporation’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Etubics Corporation
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Etubics Corporation’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Etubics Corporation Snapshot

Etubics Corporation Overview

Key Information

Key Facts

Etubics Corporation - Research and Development Overview

Key Therapeutic Areas

Etubics Corporation - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Etubics Corporation - Pipeline Products Glance

Etubics Corporation - Clinical Stage Pipeline Products

Phase I Products/Combination Treatment Modalities

Etubics Corporation - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Etubics Corporation - Drug Profiles

ETBX-011

Product Description

Mechanism of Action

R&D Progress

Ebola vaccine

Product Description

Mechanism of Action

R&D Progress

ETBX-021

Product Description

Mechanism of Action

R&D Progress

Gene Therapy for Auditory Disorders

Product Description

Mechanism of Action

R&D Progress

Gene Therapy to Activate Acid Alpha-Glucosidase for Pompe Disease

Product Description

Mechanism of Action

R&D Progress

HIV vaccine

Product Description

Mechanism of Action

R&D Progress

influenza [strain H1N1] (mutivalent) vaccine

Product Description

Mechanism of Action

R&D Progress

Vaccine for HPV Associated Head and Neck Squamous Cell Carcinoma

Product Description

Mechanism of Action

R&D Progress

Vaccine for Oncology

Product Description

Mechanism of Action

R&D Progress

chikungunya vaccine

Product Description

Mechanism of Action

R&D Progress

lassa fever vaccine

Product Description

Mechanism of Action

R&D Progress

Etubics Corporation - Pipeline Analysis

Etubics Corporation - Pipeline Products by Target

Etubics Corporation - Pipeline Products by Route of Administration

Etubics Corporation - Pipeline Products by Molecule Type

Etubics Corporation - Pipeline Products by Mechanism of Action

Etubics Corporation - Recent Pipeline Updates

Etubics Corporation - Dormant Projects

Etubics Corporation - Locations and Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Etubics Corporation, Key Information

Etubics Corporation, Key Facts

Etubics Corporation - Pipeline by Indication, 2016

Etubics Corporation - Pipeline by Stage of Development, 2016

Etubics Corporation - Monotherapy Products in Pipeline, 2016

Etubics Corporation - Phase I, 2016

Etubics Corporation - Preclinical, 2016

Etubics Corporation - Discovery, 2016

Etubics Corporation - Pipeline by Target, 2016

Etubics Corporation - Pipeline by Route of Administration, 2016

Etubics Corporation - Pipeline by Molecule Type, 2016

Etubics Corporation - Pipeline Products by Mechanism of Action, 2016

Etubics Corporation - Recent Pipeline Updates, 2016

Etubics Corporation - Dormant Developmental Projects,2016

List of Figures

Etubics Corporation - Pipeline by Top 10 Indication, 2016

Etubics Corporation - Pipeline by Stage of Development, 2016

Etubics Corporation - Monotherapy Products in Pipeline, 2016

Etubics Corporation - Pipeline by Target, 2016

Etubics Corporation - Pipeline by Route of Administration, 2016

Etubics Corporation - Pipeline by Molecule Type, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll